Arca
Skip to content
Tools
Tools

ACHE: Acetylcholinesterase

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Hydrolyzes rapidly the acetylcholine neurotransmitter released into the synaptic cleft allowing to terminate the signal transduction at the neuromuscular junction.

  • Drugs that act on it: 19
  • Approved: 16
  • In phases 1 to 3: 3
  • Sponsors: 13

Who Is On It, and How Far Along

Every drug ChEMBL records acting on ACHE, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule

Approved16

  • Donepezil
  • Neostigmine
  • Galantamine
  • Pyridostigmine
  • Benzgalantamine
  • Echothiophate
  • Minaprine
  • Pralidoxime
  • Ambenonium
  • Demecarium
  • Distigmine
  • Edrophonium
  • Hexafluorenium
  • Isoflurophate
  • Physostigmine
  • Propanidid

Phase 32

  • Itopride
  • Acotiamide

Phase 21

  • Huperzine a

Phase 10

    Sponsors

    Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

    Modalities

    Drugs on this target by ChEMBL molecule type.

    • Small molecule19100%

    The Landscape

    Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. 18 of 19 act as: Acetylcholinesterase inhibitor; the rest name their own mechanism.
    DonepezilApprovedEisaiSmall moleculeInhibitor—29—
    NeostigmineApprovedArma Ltd.Small moleculeInhibitor—28—
    GalantamineApprovedJohnson & JohnsonSmall moleculeInhibitor—9—
    PyridostigmineApprovedBausch HealthSmall moleculeInhibitor—9Boxed warning
    BenzgalantamineApprovedAlpha CognitionSmall moleculeInhibitor—1—
    EchothiophateApproved—Small moleculeInhibitor—1—
    MinaprineApprovedAstraZeneca PharmaceuticalsSmall moleculeInhibitor—1Withdrawn
    PralidoximeApprovedPfizerSmall moleculeActivatorAcetylcholinesterase activator1—
    AmbenoniumApprovedSanofiSmall moleculeInhibitor—0—
    DemecariumApprovedMerck & Co. (MSD)Small moleculeInhibitor—0—
    DistigmineApproved—Small moleculeInhibitor—0—
    EdrophoniumApprovedPAI Holdings PharmSmall moleculeInhibitor—0—
    HexafluoreniumApprovedViatrisSmall moleculeInhibitor—0—
    IsoflurophateApprovedMerck & Co. (MSD)Small moleculeInhibitor—0—
    PhysostigmineApprovedAstraZeneca PharmaceuticalsSmall moleculeInhibitor—0—
    PropanididApproved—Small moleculeInhibitor—0Withdrawn
    ItopridePhase 3Getz PharmaSmall moleculeInhibitor—6—
    AcotiamidePhase 3Getz PharmaSmall moleculeInhibitor—2—
    Huperzine aPhase 2Wanbangde Pharmaceutical Group Co., LTDSmall moleculeInhibitor—8—

    Open Trials

    The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 48 in all, from ClinicalTrials.gov.
    PET Imaging of the sigma1 Receptor in Healthy AdultsDonepezilPhase 1RecruitingYale University2026-11-04
    Oral Gabapentin Versus Intravenous Neostigmine/Atropine Versus Combination of Both for Prevention of PDPHNeostigminePhase 2 / Phase 3RecruitingAssiut University2026-11-04
    Pharmacokinetics of Huperzine A Oral Solution in Healthy ParticipantsHuperzine aPhase 1Not yet recruitingWanbangde Pharmaceutical Group Co., LTD2026-08-25
    Magnesium Sulphate With Atropine and Pralidoxime vs Standard Therapy Alone in Acute Organophosphate PoisoningPralidoximeNot applicableRecruitingMuhammad Aamir Latif2026-08-20
    A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2511 in Participants With Early Alzheimer's Disease (AD)DonepezilPhase 1Not yet recruitingEisai Inc.2026-08-17
    Unilateral Spinal vs General Anaesthesia in Low EF Patients: A Hemodynamic ComparisonNeostigmine—Enrolling by invitationSargodha Medical College2026-08-07
    Vonoprazan Alone vs With Itopride for Functional Dyspepsia: The VIVA TrialItoprideNot applicableRecruitingAsian Institute of Gastroenterology, India2026-07-28
    Study on Neostigmine Acupoint Injection at Zusanli(ST36) for Treating Mechanical Ventilation-Associated Gastrointestinal DysfunctionNeostigmineNot applicableNot yet recruitingSoutheast University, China2026-07-09
    Efficacy of Lymphatic-Venous Anastomosis Plus Donepezil Versus Donepezil Alone for Alzheimer's DiseaseDonepezilNot applicableNot yet recruitingShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University2026-07-02
    A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)Galantamine, BenzgalantaminePhase 4RecruitingAlpha Cognition, Inc2026-06-08
    Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)GalantaminePhase 2 / Phase 3RecruitingNorthwell Health2026-06-04
    Postoperative GI Dysfunction and Nutrition in Malnourished Cancer Surgery PatientsNeostigmine—Not yet recruitingArma Ltd.2026-06-03
    Evaluating the Efficacy and Safety of Lecanemab in Alzheimer's Disease Through Multi-omics ApproachsDonepezilPhase 4RecruitingFirst Affiliated Hospital of Wenzhou Medical University2026-05-22
    Evaluation of Echothiophate in Pediatric Patients With Refractory AmblyopiaEchothiophatePhase 2Not yet recruitingUniversity of Oklahoma2026-04-28
    Antagonism of Neostigmine in Continuous Infusion of MivacuriumNeostigmineNot applicableNot yet recruitingBeijing Tongren Hospital2026-04-13
    Comparing Acotiamide and Itopride for the Management of IndigestionAcotiamide, ItopridePhase 4Not yet recruitingAga Khan University2026-03-04
    Impact of Sugammadex Versus Neostigmine on Early Postoperative Pulmonary FunctionNeostigmineNot applicableRecruitingShanghai Pulmonary Hospital, Shanghai, China2025-12-30
    Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body DementiaGalantaminePhase 4RecruitingVirginia Commonwealth University2025-12-16
    Neuromuscular Blocking Agents on Gastrointestinal Function Following Colorectal SurgeryNeostigminePhase 3Not yet recruitingXijing Hospital2025-12-09
    Emergence AgitationNeostigmineNot applicableActive, not recruitingAin Shams University2025-11-28
    Intravenous Infusion of Umbilical Cord Blood as an Adjunctive Treatment for Alzheimer's DiseaseDonepezil, GalantamineEarly phase 1RecruitingAnhui Provincial Hospital2025-10-06
    Acotiamide vs Itopride in Postprandial Distress SyndromeAcotiamide, ItopridePhase 3Not yet recruitingGetz Pharma2025-09-15
    Postprandial Distress Itopride Cohort TrialItopride—Not yet recruitingUniversitaire Ziekenhuizen KU Leuven2025-09-10
    An Observational Study on Lecanemab Treatment for Early Alzheimer's DiseaseDonepezil—RecruitingFirst Affiliated Hospital of Zhejiang University2025-09-04
    Efficacy of Donepezil in Patients With Chronic TinnitusDonepezilPhase 4Active, not recruitingUniversity of Sao Paulo2025-09-04
    Therapeutic Efficacy of Monoclonal Antibody Drugs for Alzheimer's Disease Based on PET ResearchDonepezil—Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine2025-09-03
    Clinical Study to Evaluate the Efficacy and Safety of Huperzine A Controlled-Release Tablets in Patients With Mild-to-Moderate Dementia of the Alzheimer's TypeHuperzine aPhase 2 / Phase 3RecruitingWanbangde Pharmaceutical Group Co., LTD2025-07-15
    Efficacy of Itopride Versus Metoclopramide in Hospitalized Medicine Patients With High Gastric Residual VolumeItopridePhase 4Not yet recruitingChulalongkorn University2025-06-22
    Exploration of the Efficacy and Mechanism of Galantamine (an Extract From Lycoris Aurea) in Treating Ischemic StrokeGalantaminePhase 2 / Phase 3RecruitingShanghai Yueyang Integrated Medicine Hospital2025-06-04
    Sugammadex-Induced Clenching During Neuromuscular Blockade ReversalPyridostigmineNot applicableRecruitingWonkwang University Hospital2025-05-08
    A Study of Novel Study Interventions and Combinations in Participants With Colorectal CancerMinaprinePhase 2Active, not recruitingAstraZeneca2025-01-27
    Telitacicept and Low-dose Steroids in Refractory Myasthenia GravisPyridostigminePhase 4Not yet recruitingFirst Affiliated Hospital of Wenzhou Medical University2024-12-09
    The Study of Ginkgo Leaf Dropping Pills and Huperzine A Injection Combined With Median Nerve Electrical Stimulation in the Treatment of Cognitive Impairment After Brain InjuryHuperzine aPhase 4RecruitingWanbangde Pharmaceutical Group Co., LTD2024-11-26
    LIFT: Life Improvement TrialPyridostigminePhase 2RecruitingBrigham and Women's Hospital2024-04-16
    Pyridostigmine for the Treatment of Constipation in Parkinson DiseasePyridostigminePhase 2RecruitingUniversity of Vermont Medical Center2022-11-03
    Masitinib in Patients With Mild Alzheimer's DiseaseGalantaminePhase 3Not yet recruitingAB Science2022-10-03
    The Effect of Huperzine A Injection on Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage: a Pilot StudyHuperzine aPhase 4Not yet recruitingWanbangde Pharmaceutical Group Co., LTD2022-09-29
    Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant EpilepsyHuperzine aPhase 2RecruitingSupernus Pharmaceuticals, Inc.2022-08-26
    Pyridostigmine Efficacy and Safety for Treatment of Ileus After Colorectal SurgeryPyridostigminePhase 2 / Phase 3RecruitingStefan Holubar MD MS FACS, FASCRS2022-04-19
    A Study of Huperzine A Injection in Reducing Postoperative Delirium in Elderly Patients Undergoing Non-cardiac SurgeryHuperzine aNot applicableRecruitingSecond Affiliated Hospital of Wenzhou Medical University2022-02-16
    Enhancing Parasympathetic Activity to Improve Endothelial Dysfunction, Vascular Oxidative Stress in African AmericansGalantaminePhase 1 / Phase 2RecruitingVanderbilt University Medical Center2021-02-24
    TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world StudyPyridostigmine—RecruitingTang-Du Hospital2019-12-02
    Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial PeritonitisItopridePhase 3RecruitingTanta University2019-11-13
    BIS-001-ER for the Treatment of Adult Focal Impaired Awareness SeizuresHuperzine aPhase 1 / Phase 2Active, not recruitingSupernus Pharmaceuticals, Inc.2018-03-23
    Comparison of Therapeutic Strategies With Cholinesterase Inhibitors (SOS TRIAL)GalantaminePhase 4Not yet recruitingUniversity Hospital, Bordeaux2018-03-06
    Vagal Stimulation in POTSPyridostigminePhase 1Active, not recruitingVanderbilt University Medical Center2017-04-21
    Effects of Huperzine a on Presbycusis(Δ,kHz, DB,MMSE, AD)Huperzine aNot applicableEnrolling by invitationZhijun Bao2017-04-05
    Droxidopa / Pyridostigmine in Orthostatic HypotensionPyridostigminePhase 2Enrolling by invitationMayo Clinic2011-06-10

    Diseases Most Associated With It

    Open Targets association score, 0 to 1; all associations
    Alzheimer disease
    0.63
    Parkinson disease
    0.62
    Neurodegenerative disease
    0.54
    Poisoning
    0.51
    Hair color
    0.48
    Abnormality of the skeletal system
    0.46
    Gastrointestinal disease
    0.46

    Genes and Related Targets

    Complexes and families that share a gene with this target
    Genes
    ACHE

    Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL220, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt P22303, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

    Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.